Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 901–1,000 of 1,004

1. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome
   Denise Battaglini, Chiara Robba, Andrea Fedele, Sebastian Trancă, Samir Giuseppe Sukkar, Vincenzo Di Pilato, Matteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, Nicolo’ Antonino Patroniti et al. · 2021 · Frontiers in Medicine
2. High Plasma Concentration of Non-Esterified Polyunsaturated Fatty Acids Is a Specific Feature of Severe COVID-19 Pneumonia
   Maxime Nguyen, Abderrahmane Bourredjem, Lionel Piroth, Bélaïd Bouhemad, Antoine Jalil, G Pallot, Naïg Le Guern, Charles Thomas, Thomas Pilot, Victoria Bergas et al. · 2020 · Scientific Reports
3. A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System
   N. Cocoros, C. Fuller, S. Adimadhyam et al. · 2021 · Pharmacoepidemiology and Drug Safety
4. Notable Developments for Vitamin D Amid the COVID-19 Pandemic, but Caution Warranted Overall: A Narrative Review
   Ronan Lordan · 2021 · Nutrients
5. Early and Significant Reduction in C‐Reactive Protein Levels After Corticosteroid Therapy Is Associated With Reduced Mortality in Patients With COVID‐19
   Zhu Cui, Zachary Merritt, Andrei Assa, Hashim Mustehsan, Erica Chung, Sichen Liu, Anand Ajit Kumthekar, Bibi Ayesha, Margaret McCort, Leonidas Palaiodimos et al. · 2021 · Journal of Hospital Medicine
6. Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
   M. Collier, Shao-Wei Zhang, N. Scrutton, F. Giorgini · 2021 · Drug Discovery Today
7. Association of Early-Phase In-Hospital Glycemic Fluctuation With Mortality in Adult Patients With Coronavirus Disease 2019
   Liangkai Chen, Wenwu Sun, Yanli Liu, Lijuan Zhang, Yanling Lv, Qiang Wang, Ding Long, Yujun Wang, Zhao Su, Shuang Rong et al. · 2021 · Diabetes Care
8. Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
   Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska, Tadeusz Wojciech Łapiński, Aleksandra Berkan‐Kawińska, Beata Bolewska, Magdalena Tudrujek‐Zdunek, Dorota Kozielewicz, Marta Rorat, Piotr Leszczyński et al. · 2021 · Journal of Clinical Medicine
9. COVID-19 myocarditis and long-term heart failure sequelae
   Jing Liu, Anita M Deswal, Umair Khalid · 2020 · Current Opinion in Cardiology
10. Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19
    Rajiv Sonti, C. William Pike, Nathan K. Cobb · 2020 · Journal of Intensive Care Medicine
11. Tocilizumab in hospitalized patients with COVID‐19: Clinical outcomes, inflammatory marker kinetics, and safety
    Joshua Aiden Hill, Manoj P. Menon, Shireesha Dhanireddy, Mark M. Wurfel, Margaret Green, Rupali Jain, Jeannie D. Chan, Joanne Huang, Danika Bethune, Cameron John Turtle et al. · 2020 · Journal of Medical Virology
12. Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity
    Kueiyu Joshua Lin, Sebastian Schneeweiß, Helen Tesfaye, Elvira D’Andrea, Jun Liu, Joyce Lii, Shawn N. Murphy, Joshua J. Gagne · 2020 · Drugs
13. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature
    Gema De Lama Caro‐Patón, Amelia Martínez de Azagra‐Garde, Alberto García‐Salido, Marta Cabrero Hernández, Amalia Tamariz‐Martel, Montserrat Nieto‐Moro · 2020 · Journal of Intensive Care Medicine
14. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model
    Yoonjung Choi, Bonggun Shin, Keunsoo Kang, Sung‐Soo Park, Bo Ram Beck · 2020 · Viruses
15. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium
    Jordi Rello, Mirko Belliato, Meletios Athanasios Dimopoulos, Evangelos J. Giamarellos‐Bourboulis, Vladimir Jaksic, Ignacio Martín‐Loeches, Iosif Mporas, Paolo P. Pelosi, Garyphallia Poulakou, Spyridon Pournaras et al. · 2020 · Anaesthesia Critical Care & Pain Medicine
16. Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository
    A. El-Solh, Umberto G. Meduri, Yolanda Lawson · 2020 · medRxiv
17. The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection
    Anna Cláudia Calvielli Castelo Branco, Maria Notomi Sato, Ricardo Wesley Alberca · 2020 · Frontiers in Cellular and Infection Microbiology
18. Acute Kidney Injury in COVID-19 Pneumonia: A Single-Center Experience in Bahrain
    Abdulraqeeb Taher, Adel A Alalwan, Naser Naser, Ola Al-Segai, Ali Al-Aradi · 2020 · Cureus
19. Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
    A. Shields, Susan Tadros, A. Al-Hakim et al. · 2022 · Frontiers in Immunology
20. Progress and pitfalls of a year of drug repurposing screens against COVID-19
    Julien Sourimant, Megha Aggarwal, Richard Karl Plemper · 2021 · Current Opinion in Virology
21. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines
    Iman Salahshoori, Noushin Mobaraki-Asl, Ahmad Seyfaee, Nasrin Mirzaei Nasirabad, Zahra Dehghan, Mehrdad Faraji, Mina Ganjkhani, Aziz Babapoor, Seyede Shadmehr, Ali Hamrang · 2021 · Biologics
22. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
    Matthew Geriak, Fadi A. Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, David C. Willms, George Sakoulas · 2021 · Infectious Diseases and Therapy
23. A Biochemical and Structural Understanding of TOM Complex Interactions and Implications for Human Health and Disease
    Ashley S. Pitt, Susan K. Buchanan · 2021 · Cells
24. Emergent Drug and Nutrition Interactions in COVID-19: A Comprehensive Narrative Review
    Duygu Ağagündüz, Menşure Nur Çelik, Merve Esra Çıtar Dazıroğlu, Raffaele Capasso · 2021 · Nutrients
25. Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?
    Nithin Kuriakose, Prakash Patil, Satheesh Kumar Bhandary, Vikram Muralidhar Haridas, Suchetha Kumari, Sarathkumar Edachery, Praveenkumar K. Shetty · 2021 · F1000Research
26. Maßnahmen zur Bewältigung der COVID-19-Pandemie in Deutschland: nichtpharmakologische und pharmakologische Ansätze
    U. Grote, Mardjan Arvand, S. Brinkwirth et al. · 2021 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
27. Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
    Miguel Ángel Martı́nez · 2021 · Antimicrobial Agents and Chemotherapy
28. Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients
    Filippo Albani, Federica Fusina, Enza Granato, Cristina Capotosto, Claudia Ceracchi, Riccardo Gargaruti, Giovanni Santangelo, Luca Schiavone, Maria Taranto, Cinzia Tosati et al. · 2021 · Scientific Reports
29. Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
    Cara A. Timpani, Emma Rybalka · 2020 · Pharmaceuticals
30. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study
    R. Ghosh, Ayon Chakraborty, Dr. Ashis Biswas · 2020 · Journal of Biomolecular Structure and Dynamics
31. Review on therapeutic targets for COVID-19: insights from cytokine storm
    Mário Luciano de Mélo Silva Júnior, Lívia Maria Alves de Souza, Renata Ellen Maria Carvalho Dutra, Ramon Gonçalves de Melo Valente, Thayanara Silva Melo · 2020 · Postgraduate Medical Journal
32. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
    Galit H. Frydman, Michael Blake Streiff, Jean M. Connors, Gregory Piazza · 2020 · TH Open
33. Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
    Youngji Jo, L. Jamieson, I. Edoka · 2020 · medRxiv
34. COVID-19: The Immune Responses and Clinical Therapy Candidates
    Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, Roozbeh Tarighati Rasekhi, Ghassem Rostamian, Mohamad Reza Kalani, Aida Rostamian, Jacob George, Mark W. Douglas · 2020 · International Journal of Molecular Sciences
35. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
    Jairo Ramos Temerozo, Carolina Q. Sacramento, Natalia Fintelman Rodrigues, Camila R. R. Pão, Caroline Souza de Freitas, Suelen da Silva Gomes Dias, André Costa Ferreira, Mayara Mattos, Vinícius Cardoso Soares, Lívia Teixeira et al. · 2022 · Journal of Leukocyte Biology
36. The scale and dynamics of COVID-19 epidemics across Europe
    Christopher Dye, Russell C. H. Cheng, J. S. Dagpunar, Brian Gerard Williams · 2020 · Royal Society Open Science
37. Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol-generating procedures (AGPs) on patients without suspected or confirmed COVID-19 infection
    Martin J Burton, Jan Clarkson, Beatriz Goulão, Anne‐Marie Glenny, Andrew J. McBain, Anne GM Schilder, Katie E Webster, Helen V Worthington · 2020 · Cochrane Database of Systematic Reviews
38. Remote Hospital Care for Recovering COVID-19 Patients Using Telemedicine: A Randomised Controlled Trial
    H. V. van Goor, M. Breteler, K. van Loon · 2021 · Journal of Clinical Medicine
39. High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit
    Felix Bongomin, Brian Fleischer, Ronald Olum, Barbra Natukunda, Sarah Kiguli, Pauline Byakika‐Kibwika, Joseph Baruch Baluku, Frederick Nelson Nakwagala · 2021 · Open Forum Infectious Diseases
40. Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression
    Liam Townsend, Adam H. Dyer, Aifric Naughton, Sultan Imangaliyev, Jean Dunne, Rachel Kiersey, Dean Holden, Aoife Mooney, Deirdre Leavy, Katie Ridge et al. · 2022 · Heliyon
41. Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa
    Ben Morton, Kayla G. Barnes, Catherine Anscombe, Khuzwayo C. Jere, Prisca Benedicto-Matambo, Jonathan J. Mandolo, Raphael Kamng’ona, Comfort Brown, James Nyirenda, Tamara Phiri et al. · 2021 · Nature Communications
42. Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection
    Subhajit Maity, A. Saha · 2021 · Frontiers in Microbiology
43. Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study
    Roshan Acharya, D. Poudel, R. Bowers et al. · 2021 · Journal of Clinical Medicine Research
44. The time to offer treatments for COVID-19
    Binh Ngo, Paul Ellis Marik, Pierre D. Kory, Leland Shapiro, Raphael Thomadsen, Jose I. Iglesias, Stephen Ditmore, Marc Rendell, Joseph Varón, Michael P. Dubé et al. · 2021 · Expert Opinion on Investigational Drugs
45. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets
    Yue Li, Ashley Duche, Michael R. Sayer, Don Roosan, Farid G. Khalafalla, Rennolds S. Ostrom, Jennifer E. Totonchy, Moom Rahman Roosan · 2021 · BMC Genomics
46. The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
    Jiasheng Wang, John Doran · 2021 · Clinical Hematology International
47. Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?
    Florian Moretto, Thibault Sixt, H. Devilliers, Maroua Abdallahoui, Isabelle Eberl, Thomas Rogier, M. Buisson, P. Chavanet, Michel Duong, Clémentine Estève et al. · 2021 · International Journal of Infectious Diseases
48. How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C
    Anjali Alatkar Sharathkumar, Edward Vincent S. Faustino, Clifford M. Takemoto · 2021 · Pediatric Blood & Cancer
49. Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC
    Hyunah Yoon, Rachel M. Bartash, Inessa Gendlina, Johanna Rivera, Antonio S. Nakouzi, Robert H. Bortz, Ariel S. Wirchnianski, Monika Paroder, Karen Fehn, Leana Serrano‐Rahman et al. · 2021 · JCI Insight
50. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2
    Kelsey E. Huntington, Anna D. Louie, Chun Geun Lee, Jack Angel Elias, Eric A. Ross, Wafik S. El‐Deiry · 2021 · eLife
51. Report 41: The 2020 SARS-CoV-2 epidemic in England: key epidemiological drivers and impact of interventions
    Edward Knock, Lilith K. Whittles, John A. Lees, Paula Guzmán, Robert Verity, Richard G. FitzJohn, Katy A. M. Gaythorpe, Natsuko Imai, Wes R. Hinsley, Lucy Okell et al. · 2020 · Spiral (Imperial College London)
52. Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group
    Chia Wei Teoh, Marie‐Michèle Gaudreault‐Tremblay, Tom David Blydt‐Hansen, Aviva M. Goldberg, Steven Arora, Janusz Feber, Valerie Langlois, Michelle Ruhl, Véronique Phan, Catherine Morgan et al. · 2020 · Canadian Journal of Kidney Health and Disease
53. Union is strength: antiviral and anti-inflammatory drugs for COVID-19
    J. Jesús Naveja, Abraham Madariaga‐Mazón, Francisco Javier Flores‐Murrieta, Julio Granados‐Montiel, Marco Antonio Maradiaga-Ceceña, Víctor Duarte-Alaniz, Maricruz Maldonado-Rodriguez, Jazmín García-Morales, Juan P. Senosiain, Karina Martínez‐Mayorga · 2020 · Drug Discovery Today
54. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab
    Bryant D. Yang, Jennifer A. Fulcher, Jenny Ahn, Marlene Berro, David Goodman‐Meza, Kush Dhody, Jonah B. Sacha, Arash Naeim, Otto O. Yang · 2020 · Clinical Infectious Diseases
55. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India
    Yojana A. Gokhale, Rakshita Mehta, Uday Prakash Kulkarni, Nitin Karnik, Sushant Gokhale, Uma Sundar, Swati Arvind Chavan, Akshay Kor, Sonal Thakur, Trupti H Trivedi et al. · 2021 · BMC Infectious Diseases
56. Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
    M. Balcells, Luis Rojas, N. Le Corre et al. · 2020 · medRxiv
57. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
    Vickie R. Shannon, Ronald Anderson, Ada Gabriela Blidner, Jennifer Nam Choi, Tim Cooksley, Michael Lawrence Dougan, Ilya G. Glezerman, Pamela Ginex, Monica Girotra, Dipti Gupta et al. · 2020 · Supportive Care in Cancer
58. JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis
    Lucas Walz, Avi J. Cohen, Andre P. Rebaza, James Vanchieri, Martin D. Slade, Charles S. Dela Cruz, Lokesh Sharma · 2020 · Research Square
59. Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
    Jay J. H. Park, E. Decloedt, C. Rayner · 2020 · Lancet Global Health
60. Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China
    Yiming Ma, Huihui Zeng, Zijie Zhan, Huanhuan Lu, Zihang Zeng, Chenjie He, Xiangming Liu, Chen Chen, Qingwu Qin, Jia He et al. · 2020 · Frontiers in Pharmacology
61. Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists
    Omid Zahedi Niaki, Milan J. Anadkat, Steven T. Chen, Lindy Peta Fox, JOANNA LEE HARP, Robert G. Micheletti, Vinod E. Nambudiri, Helena B. Pasieka, Michi M. Shinohara, Misha A. Rosenbach et al. · 2020 · Journal of the American Academy of Dermatology
62. Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience
    Ivan Gentile, Giulio Viceconte, Amedeo Lanzardo, Irene Zotta, Emanuela Zappulo, Biagio Pinchera, Riccardo Scotto, Nicola Schiano Moriello, Maria Foggia, Agnese Giaccone et al. · 2021 · International Journal of Environmental Research and Public Health
63. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature
    Madeleine R. Heldman, Olivia S. Kates · 2021 · Current treatment options in infectious diseases/Current treatment options in infectious disease
64. Outcomes of Barotrauma in Critically Ill COVID-19 Patients With Severe Pneumonia
    Victor P. Gazivoda, Mudathir Ibrahim, Aaron W. Kangas-Dick, Arony J. Sun, Michael P. Silver, Ory Wiesel · 2021 · Journal of Intensive Care Medicine
65. Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?
    M. Gelzo, S. Cacciapuoti, B. Pinchera et al. · 2021 · Frontiers in Public Health
66. Initial experience of bamlanivimab monotherapy use in solid organ transplant recipients
    Heather L. Kutzler, Hillary A. Kuzaro, Oscar Kenneth Serrano, Andrew D. Feingold, Glyn Morgan, Faiqa Cheema · 2021 · Transplant Infectious Disease
67. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options
    Ashli Heustess, Melissa Allard, Dorothea K. Thompson, Pius S. Fasinu · 2021 · Pharmaceuticals
68. Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy
    José F. Camargo, Maria A. Mendoza, Rick Y. Lin, Ilona V. Moroz, Anthony D. Anderson, Michelle I. Morris, Yoichiro Natori, Akina Natori, Mohammed A. Raja, Lazaros J. Lekakis et al. · 2021 · Transplant Infectious Disease
69. COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment
    Vera Hapshy, Daniel Aziz, Payal Kahar · 2021 · SN Comprehensive Clinical Medicine
70. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129
    Lina Badimón, Emma Louise Robinson, Amela Jusić, Irina Carpusca, León J. De Windt, Costanza Emanueli, Péter Ferdinandy, Wei Gu, Mariann Gyöngyösi, Matthias Hackl et al. · 2021 · Cardiovascular Research
71. Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices
    Argyro Pountoukidou, Maria Potamiti-Komi, Vrisiis Sarri, Michail Papapanou, Eleni Routsi, Anna Maria Tsiatsiani, Nikolaos Vlahos, Charalampos S Siristatidis · 2021 · Healthcare
72. Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?
    Allan Kalungi, Eugene Kinyanda, Dickens Howard Akena, Pontiano Kaleebu, Innocent M. Bisangwa · 2021 · Frontiers in Immunology
73. Trends in Risk‐Adjusted 28‐Day Mortality Rates for Patients Hospitalized with COVID‐19 in England
    Simon Jones, Neil Thomas Mason, Tom Palser, Simon Swift, Christopher Michael Petrilli, Leora Idit Horwitz · 2021 · Journal of Hospital Medicine
74. Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
    Ching‐Hsuan Liu, Cheng-Hua Lu, Shu Hui Wong, Liang Lin · 2021 · Frontiers in Immunology
75. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
    Talvinder Bhogal, Umair Khan, Rebecca J. Lee, Alexander J. Stockdale, Christian Hesford, Vaishnav Potti-Dhananjaya, Avith Jathanna, Shaun Rahman, Ann Tivey, Rohan Shotton et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
76. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy
    Elyse Latreille, Warren L. Lee · 2021 · Viruses
77. Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19
    Shayan Kassirian, Ravi Taneja, Sanjay Mehta · 2020 · Diagnostics
78. Protease inhibitors targeting the main protease and papain-like protease of coronaviruses
    Clemente Capasso, Alessio Nocentini, Claudiu Trandafir Supuran · 2020 · Expert Opinion on Therapeutic Patents
79. Potential role of viral metagenomics as a surveillance tool for the early detection of emerging novel pathogens
    Hareem Mohsin, Azka Asif, Minhaj Fatima, Yasir Rehman · 2020 · Archives of Microbiology
80. Activities of Serum Ferritin and Treatment Outcomes Among COVID-19 Patients Treated With Vitamin C and Dexamethasone: An Uncontrolled Single-Center Observational Study
    Hemanth Reddy Burugu, Venkataramana Kandi, L. V. Simhachalam Kutikuppala, Tarun Kumar Suvvari · 2020 · Cureus
81. Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease
    Stuti Bhagat, Nisha Yadav, Juhi Shah, Harsh Dave, Shachee Swaraj, Shashank Tripathi, Sanjay Singh · 2020 · Expert Review of Anti-infective Therapy
82. Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis
    J. Ladapo, J. McKinnon, P. McCullough · 2020 · medRxiv
83. Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis
    Stephen E. Congly, Rhea A. Varughese, Crystal E. Brown, Fiona M Clement, Lynora M. Saxinger · 2021 · Scientific Reports
84. Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All
    G. Waterer, J. Rello · 2020 · Infectious Disease and Therapy
85. Effectiveness and safety of noninvasive positive pressure ventilation in the treatment of COVID-19-associated acute hypoxemic respiratory failure: a single center, non-ICU setting experience
    Antonio Faraone, Chiara Beltrame, Andrea Crociani, Paolo Carrai, Elena Lovicu, Simona Filetti, Serena Sbaragli, Chiara Alessi, Michela Cameron Smith, Chiara Angotti et al. · 2020 · Internal and Emergency Medicine
86. Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2
    Kim, Jeonghwan, Mukherjee, Anindit, Nelson, Dylan, Jozic, Antony, Sahay, Gaurav · 2020
87. Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan
    Marie Warrer Petersen, Tine Sylvest Meyhoff, Marie Helleberg, Maj‐Brit Nørregaard Kjær, Anders Granholm, Carl Johan Steensen Hjortsø, Thomas Steen Jensen, Morten Hylander Møller, Peter Buhl Hjortrup, Mik Wetterslev et al. · 2020 · Acta Anaesthesiologica Scandinavica
88. An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19
    Reuben McGregor, Daniel Chauss, Tilo Freiwald, Bingyu Yan, Luopin Wang, Estefanía Nova‐Lamperti, Zonghao Zhang, Heather Teague, Erin E. West, Jack A. Bibby et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
89. Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials
    Juan Arturo Siordia, Michael Bernaba, Kenji Yoshino, Abid Ulhaque, Sooraj Kumar, Mario Bernaba, Edward Bergin · 2020 · SN Comprehensive Clinical Medicine
90. Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
    Gerard J. Criner, Frederick M. Lang, Robert Gottlieb, Kusum S. Mathews, Tisha S. Wang, Todd W. Rice, Deepu Madduri, Shashi Bellam, Robert Jeanfreau, Amy H. Case et al. · 2022 · American Journal of Respiratory and Critical Care Medicine
91. Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
    James Welker, Juan D Pulido, Andrew T Catanzaro, Carlos D Malvestutto, Zihai Li, Jonathan B Cohen, Eric D Whitman, Dana Byrne, Olivia K Giddings, Jordan E Lake et al. · 2022 · The Lancet Infectious Diseases
92. SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
    Patrida Rangchaikul, Vishwanath Venketaraman · 2021 · Infectious Disease Reports
93. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
    Yi Wang, Sui Fang, Yan Wu, Xi Cheng, Leike Zhang, Xu-Rui Shen, Shuangqu Li, Jianrong Xu, Weijuan Shang, Zhaobing Gao et al. · 2021 · Acta Pharmacologica Sinica
94. Single paternal dexamethasone challenge programs offspring metabolism and reveals multiple candidates in RNA-mediated inheritance
    Katharina Gapp, Guillermo E. Parada, Fridolin Groß, Alberto Corcoba, Jasmine Kaur, Evelyn Grau, Martin Hemberg, Johannes Bohacek, Eric Alexander Miska · 2021 · iScience
95. Case Management of COVID-19 (Secondary Version)
    Y. Kato · 2021 · JMA Journal
96. Lupus, vaccinations and COVID-19: What we know now
    Alice Mason, Himashi Anver, May Lwin, Christopher R. Holroyd, Saul N. Faust, Christopher John Edwards · 2021 · Lupus
97. Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey
    Britta Franziska Zecher, Gustav Buescher, José Willemse, Martine Walmsley, Alison H. M. Taylor, Angela Leburgue, Christoph Schramm, Ansgar Wilhelm Lohse, Marcial Sebode · 2021 · United European Gastroenterology Journal
98. Bacterial infection, antibiotic use and COVID-19: Lessons from the intensive care unit.
    M. Moolla, K. Reddy, I. Fwemba et al. · 2021 · South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
99. Cardiovascular Injury Due to SARS-CoV-2
    Christina L. Bugert, Victoria R. Kwiat, Isela Valera, Joachim J. Bugert, Michelle S. Parvatiyar · 2021 · Current Clinical Microbiology Reports
100. Update in Viral Infections in the Intensive Care Unit
     Paraskevi C. Fragkou, Charalampos D. Moschopoulos, Emmanouil Karofylakis, Theodoros Kelesidis, Sotirios Tsiodras · 2021 · Frontiers in Medicine